For Adult blood type incompatibility liver transplant and lymphocyte cross-match cases against humoral rejection A.surgery and anti-blood antibody lowering therapy due to previous anti-Bcell monoclonal antibodies, and plasma exchange B.post-transplantation and hepatic artery in early, portal vein infusion therapy And humoral rejection Y globulin therapy and plasma exchange combination therapy as a treatment for the reaction onset
Not Applicable
Recruiting
- Conditions
- iving-donor liver transplantation
- Registration Number
- JPRN-UMIN000018224
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patient consent was not obtained in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Complication rate (Clavine-Dindo classification) Graft survival rate